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A B S T R A C T
Social anxiety disorder (SAD) is a common mental disorder with high persistence when untreated. As access to
eﬀective treatment is limited, guided internet-based cognitive behavioral therapy (ICBT) has been proposed as
an eﬀective alternative to face-to-face treatment. In this study, we examined the eﬀectiveness of a 14-week
therapist-guided ICBT program for patients with SAD undergoing routine care. From 2014 to 2017, 169 patients
were included in the study, of which 145 started the treatment. The sample was all general practitioner-referred
and had a lower educational level and higher rate of work absence compared to similar eﬀectiveness studies.
Regarding social anxiety symptoms, we identiﬁed signiﬁcant within-group eﬀect sizes (post-treatment:
d=1.00–1.10; six-month follow-up: d=1.03–1.55). We also found signiﬁcant eﬀects on secondary depression
symptoms (d=0.67). Clinically signiﬁcant improvement was reported by 66.2% of the participants, and 16.6%
had a signiﬁcant deterioration. Clinical implications of the current study are that guided ICBT for SAD is an
eﬀective treatment for the majority of the patients undergoing routine care. Future studies should explore in-
terventions targeting non-responders and deteriorated patients.
1. Introduction
Social anxiety disorder (SAD) is associated with a fear of being
negatively evaluated by others in social performance or interaction si-
tuations (Stein, 2008). It is a disorder with a global lifetime prevalence
of 4.0%, with a somewhat higher percentage in high-income countries
(Stein et al., 2017). The disorder is more prevalent in females than
males; however, males tend to seek help more often than females (Asher
et al., 2017). The median age of onset across Europe is in the mid-teens
(11–17 years; Stein et al., 2017). The disorder negatively aﬀects social
and romantic relationships and academic and career achievements
(Asher et al., 2017). From the perspective of the burden on society, SAD
is associated with higher risks of school dropout and work absenteeism
compared to the general population (Griﬃths, 2013). Access to treat-
ment for SAD is limited owing to a lack of available services and a fear
of stigma (Shafran et al., 2009). Speciﬁc to SAD is also the fact that the
symptoms are often perceived as personal traits like shyness, and not as
a common mental disorder that may be eﬀectively treated (Griﬃths,
2013). Overall, SAD is associated with large individual and societal
burdens owing to its early onset, persistence when left untreated, and
high prevalence, which is why it is important to increase access to care
for this group.
Clinical guidelines for the psychological treatment of SAD re-
commend cognitive behavioral therapy (CBT) as an individual face-to-
face treatment (United Kingdom: National Institute of Clinical
Excellence, CG159 ICE), or in the form of guided internet-based CBT
(ICBT; Sweden: Socialstyrelsen, 2017). The ﬁrst eﬃcacy trial on the
subject were published> 10 years ago and reported large eﬀects of a
guided ICBT program combined with two in-vivo exposure sessions
(Andersson et al., 2006). In another early randomized controlled trial
comparing telephone-supported ICBT to waiting list, the results showed
large treatment eﬀects for the intervention group but not for the control
group (Carlbring et al., 2007). The results remained the same at the 30-
month follow-up (Carlbring et al., 2009). Tillfors et al. (2008)
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compared guided ICBT inclusive of ﬁve exposure sessions to guided
ICBT alone. The results showed large within-group eﬀect sizes at post-
treatment and at the one-year follow-up in both groups, with no be-
tween-group diﬀerences. Nordmo et al. (2015) compared the eﬀects of
combining guided ICBT with an initial face-to-face psychoeducation
session (90min) to guided ICBT without an initial face-to-face psy-
choeducation session. The results showed moderate to large within-
group treatment eﬀects, and no signiﬁcant diﬀerences between the two
groups.
The eﬀects reported in 21 trials of guided and unguided ICBT for
SAD (N=1801) were reviewed by Boettcher and colleagues (Boettcher
et al., 2013). Overall, there were large within-group eﬀects at post-as-
sessment, three-month follow-up, and ﬁve-year follow-up. Also, a
moderate eﬀect on comorbid depression was reported. In a recent meta-
analysis of 20 randomized controlled trials comparing face-to-face
treatment and guided ICBT (Carlbring et al., 2018), including three
studies on SAD, no signiﬁcant diﬀerences between guided ICBT and
face-to-face treatments were identiﬁed.
In spite of an increasing number of studies conﬁrming the eﬃcacy of
guided ICBT for SAD, it is rarely implemented in routine practice
(Olthuis et al., 2016), and only a few eﬀectiveness trials have been
conducted.
In an eﬀectiveness study (N=654) from the specialist internet
treatment clinic in Sweden, large within-group eﬀect sizes of guided
ICBT have been reported (Cohen's d=0.86–1.15; El Alaoui et al.,
2015). In this study, 90% of the sample was self-referred, 3% was on
sick leave, and 8% was unemployed. On average, participants com-
pleted eight out of the 12 modules in the guided ICBT manual. In an
eﬀectiveness trial comparing a stepped-care approach (psychoeduca-
tion, guided ICBT, 12 sessions of face-to-face treatment) to 12 sessions
of face-to-face treatment, 80% of the patients who recovered did so
after guided ICBT (Nordgreen et al., 2016). From an eﬀectiveness trial
of transdiagnostic guided ICBT for anxiety and depression, moderate
eﬀects (d=0.63) of SAD symptoms were reported (Newby et al.,
2014). Another small trial (N=37) reported no diﬀerence between
face-to-face therapy and guided ICBT for SAD patients (Andrews et al.,
2011). Even if routine care is used as a distinct category across the
eﬀectiveness trials, it diﬀers when it comes to patients' access to care.
The majority of the previously conducted eﬀectiveness trials were on
self-referred samples. We know that self-referral is associated with
higher eﬀects compared to general practitioner (GP)-referred samples
(Haug et al., 2012). It is therefore, important to gain knowledge about
the eﬀectiveness of guided ICBT in a setting where patients are GP
referred, which is what this study set out to achieve.
2. Method
2.1. Setting
Since 2013, the eCoping (eMeistring.no) clinic at Haukeland
University Hospital, Bergen, Norway, has oﬀered guided ICBT for panic
disorder (Nordgreen et al., 2018) and SAD in routine mental health
outpatient care settings. ICBT for depression was introduced in the
clinic in 2015. The clinic is part of the Division of Psychiatry, Hauke-
land University Hospital, Norway. The catchment area of the hospital is
250,000 persons and comprises three mental health outpatient clinics.
The Western Regional Committee for Medical and Health Research
Ethics in Norway approved the present study (2012/2211/REK).
2.2. Design
This trial was an open eﬀectiveness study with a naturalistic within-
group design with repeated primary and secondary treatment outcomes
and six-month follow-up.
2.3. Procedure
All patients admitted for specialized mental health treatment in
Norway must be referred by their GP. Accordingly, referred patients
admitted for treatment were invited for an initial face-to-face assess-
ment interview at the clinic. During this meeting, patients were in-
formed about guided ICBT as one of the treatment alternatives avail-
able.
All patients referred to one of the three mental health outpatient
clinics for SAD and who were willing to consider guided ICBT as a
treatment alternative were invited to a diagnostic assessment using the
Mini International Neuropsychiatric Interview (MINI; Sheehan et al.,
1998). Patients who were interested in starting guided ICBT and ful-
ﬁlled the inclusion criteria were oﬀered ICBT and invited to participate
in this trial. The following inclusion criteria were used: 1) SAD as the
main problem according to the MINI, 2) 18 years of age or older, 3) not
using benzodiazepines on a daily basis, 4) if using antidepressants, a
stable dosage over the previous four weeks, and 5) able to read and
write in Norwegian. The exclusion criteria were: 1) current suicidal
ideation, 2) current psychosis, 3) current substance abuse, 4) in im-
mediate need of other treatment, and 5) no access to the internet. All
participants signed a written informed consent form.
2.4. Treatment
The guided ICBT treatment program used in the present study builds
on research from Sweden (Furmark et al., 2009; Hedman et al., 2014).
The program was translated into Norwegian in 2007. Two previous
studies on telephone-supported ICBT for SAD were reported from our
research group (Nordgreen et al., 2016; Nordmo et al., 2015), with
large eﬀect sizes reported in both studies. Based on the preliminary
results from these studies, guided ICBT for SAD was integrated into
routine care in 2013.
The ICBT program for SAD comprises nine online text-based mod-
ules that include psychoeducation, working with automatic thoughts,
behavioral experiments, shifting focus, and relapse prevention. The
main part of treatment is deﬁned as completing the ﬁrst ﬁve modules
with the following content: psychoeducation, working with automatic
thoughts, and behavioral experiments. The treatment lasts up to
14 weeks. The patients spend an average of 7–10 days per module and
access each module after completing the previous one. Therapist gui-
dance was given at least once a week through a secure email system.
The therapist provided guidance of an average of 10–15min per week
per patient. The treatment was implemented on an existent, secure self-
report assessment IT platform.
2.5. Training
The therapists at eMeistring are co-located for one to two days per
week for working with guided ICBT, with an ordinary workload during
the rest of the week. In addition to a one-year continuing education,
there was weekly peer supervision and monthly expert supervision.
2.6. Measures
Owing to a limitation in the platform, the self-report assessment
measures were made accessible to the patients at the end of the module
and not on a ﬁxed timeline (e.g., every seven days).
2.7. Primary outcome measure
The Social Phobia Scale (SPS; Mattick and Clarke, 1998) includes 20
items rated from 0 to 4. The SPS is used to assess self-reported symp-
toms of SAD in performance situations (pretreatment Cronbach's
alpha=0.91). The scores on the SPS were assessed at pretreatment,
after modules two–eight, at post-treatment, and at the six-month
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follow-up.
2.8. Secondary outcome measures
The Social Interaction Anxiety Scale (SIAS; Mattick and Clarke,
1998) includes 20 items rated from 0 to 4. The SIAS is used to assess
self-reported symptoms of SAD in social interaction situations (pre-
treatment Cronbach's alpha= 0.89). The scores on the SIAS were as-
sessed at pretreatment, after modules three and six, at post-treatment,
and at the six-month follow-up.
The Montgomery-Åsberg Depression Rating Scale-self report
(MADRS-SR; Svanborg and Asberg, 2001) includes nine items rated
from 0 to 6. The MADRS-SR is used to assess self-reported measures for
depressive symptoms during the previous three days (pretreatment
Cronbach's alpha= 0.83). The scores on the MADRS-SR were assessed
at pretreatment, after modules one–eight, at post-treatment, and at the
six-month follow-up.
The Credibility Scale (Borkovec and Nau, 1972) includes ﬁve items
rated from 1 to 10. The C-scale was used to measure treatment cred-
ibility at the end of module one, when patients were familiar with the
treatment format but still had limited exposure to the treatment content
(pretreatment Cronbach's alpha= 0.89).
2.9. Statistical analysis
Descriptive statistics, frequencies, chi-square tests, and t-tests were
analyzed with SPSS 24 (IBM Corp, 2017), while latent growth curve
(LGC) models were analyzed with Mplus 8.0 (Muthén and Muthén,
2017). Linear LGC models were analyzed with speciﬁcations of all
points of time between the ﬁrst and last measurement points as free
time factors to explore the degree of change at each module level
(Bollen and Curran, 2006; Wang and Wang, 2012). The estimator was
maximum likelihood with robust standard errors (MLR) to estimate
unbiased standard errors due to some non-normality in data (Kline,
2010). The full information maximization likelihood method provides
estimates based on all available data and assumes “missing at random”
(Muthén and Muthén, 2017).
Within-group eﬀect sizes used the magnitude of change from pre- to
post-treatment and follow-up, respectively, divided by pretreatment
standard deviations (Cohen and Cohen, 1983).
SPS at post-assessment was used to estimate clinically signiﬁcant
change. Clinically signiﬁcant change at an individual level was esti-
mated using the Jacobson and Truax (1991) formula of reliable change
combined with the C criteria for clinical change according to the cutoﬀ
for caseness as reported in the literature. Reliable change was calcu-
lated using the change score divided by standard error of diﬀerence at
pretreatment (Sdiﬀ=1.73; improvement or deterioration ±
SPS=3.39≈ 3; Rozental et al., 2017). The cutoﬀ for caseness on the
SPS was set to ≤25, in accordance with previous studies (Nordgreen
et al., 2016; McEvoy, 2007).
3. Results
3.1. Participants
A total of 222 patients referred during the study period—August
2014–2017—were eligible for guided ICBT for SAD and invited to
participate in the study. A total of 169 patients were included in the
study, all GP-referred. The El Alaoui study (El Alaoui et al., 2015) is
comparable to the present study regarding the percentage of females,
mean age, marital status, and years of complaints. However, the per-
centages of those with higher education (+12 years) (29%) and pa-
tients on sick leave were higher in the present study. Demographics and
former help-seeking behavior are presented in Table 1.
3.2. Attrition
A total of 169 patients were included in the study, and 145 patients
(85.8%) subsequently started treatment. Among these 145, a total of
113 (77.9%) responded to the post-treatment assessment, and 52
(35.9%) responded to the six-month follow-up.
No signiﬁcant diﬀerences regarding age (t (166)= 1.67, p= .10),
gender (χ (1)= 2.61, p= .11, or pretreatment level of self-reported
symptoms (SPS= t(167)= 0.09, p= .93; SIAS= t(167)= 0.18,
p= .86; MADRS-SR= t(167)= 1.86, p= .07) were identiﬁed between
those who did and did not start treatment. No signiﬁcant diﬀerences
were identiﬁed between patients who provided six-month follow-up
data and those who did not with regard to gender (p= .25) or pre-
treatment symptoms (SPS, p= .36; SIAS, p= .23; MADRS-SR, p= .07).
However, there was a signiﬁcant diﬀerence (166)= 2.57, p= .01) with
regard to the age of the patients who did not complete the follow-up
assessment (28.5 years old) and those who did (33.1 years old).
3.3. Pretreatment level and change during treatment period
Mean pretreatment levels and the mean change for the three out-
come variables are illustrated in Table 2 (N=169). Variables were
normally distributed (skewness=−0.20 to 0.09; kurtosis=−0.84 to
−0.64). All outcome variables showed statistically signiﬁcant mean
reductions during treatment. Statistically signiﬁcant individual varia-
tions, both in baseline and change scores, were seen. The negative
correlations between baseline and change indicate that patients with
higher pretreatment symptoms showed a larger reduction during
treatment compared to patients with lower levels of pretreatment
symptoms. The estimated values for the SPS, SIAS, and MADRS-SR for
each module are presented in Table 3.
3.4. Magnitude of change across modules
The magnitude of change across modules is illustrated in Fig. 1. The
curve shows the percentage of total change at each module at the pri-
mary (SPS) and secondary (SIAS and MADR-SR) outcome measures.
3.5. Changes from post-treatment to six-month follow-up
Changes from post-treatment to six-month follow-up were not sta-
tistically signiﬁcant for the primary outcome measure SPS
(Δpost,FU=−0.53, p= .753) with a pretreatment to follow-up
ES= 1.01 (Table 2). On the SIAS, (Δpost,FU=−4.67, p= .006) a highly
signiﬁcant mean reduction was found with a pretreatment to follow-up
ES= 0.93 (Table 2). No signiﬁcant mean change was found in the
MADRS-SR (Δpost,FU= 0.17, p= .885) with a pretreatment to follow-up
ES= 0.79 (Table 2).
Statistically signiﬁcant individual variations in change were found
Table 1
Demographics and former help-seeking behaviour.
n/N mean %/SD Range
Female 96/169 56.8%
Years 29.8 10.6 17.0–63.0
Married/cohabitant 66/166 39.8%
Children 41/167 24.6%
Higher educationa 49/169 29.0%
Years of complaints 13.8 11.3 (0.2–50.0)
On sick leave, disability pension, unemployed 60/167 35.9%
Psychotropic medication last three months 68/169 40.2%
Previous mental health treatmentb 135/169 79.9%
Note. N=169. M=mean. SD= standard deviation.
a College or university level.
b Previous 6 months.
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for all three variables (SPS: SD=8.38, p < .001; SIAS: SD=9.92,
p < .001; MADRS-SR: SD=6.00, p= .005).
3.6. Modules completed
Patients completed a mean of 5.3 modules (range= 0–9,
SD=3.02) out of the nine modules. A total of 96 (66.2%) of the 145
patients who started treatment also completed the main parts of the
treatment (ﬁve out of nine modules).
3.7. Clinically signiﬁcant change and deterioration
Signiﬁcant improvement according to the Jacobsen and Truax
(1991) formula was identiﬁed in 96 of the 145 patients (66.2%) who
started the treatment (Table 4). Signiﬁcant improvement according to
the Jacobsen and Truax (1991) formula was identiﬁed in 73 of the 96
patients (76.0%) who completed ﬁve or more treatment modules. Sig-
niﬁcant deterioration according to the Jacobsen and Truax (1991)
formula was identiﬁed in 24 of the 145 patients (16.6%) who started
the treatment (Table 4), with the majority (n=14) stopping treatment
between modules one and four. Deteriorated patients were oﬀered face-
to-face treatment at the clinic.
Table 2
Latent change results with mean and individual diﬀerences (standard deviation, SD) in baseline (Intercept I) and change in the total follow-up period (Slope S).
Baseline (I) Change (S)
Mean SD p Mean p SD p ESa ESb ri,s p
SPS 40.56 15.14 .001 −15.14 .001 14.94 .001 1.00 1.01 0.24 .012
SIAS 45.89 10.39 . 001 −11.47 .001 12.37 .001 1.10 0.93 0.23 .092
MADRS-SR 17.66 7.53 . 001 −5.05 .001 6.36 .001 0.67 0.79 0.17 .179
Note. N=169. I= intercept. S= slope. SPS= Social Phobia Scale. SIAS= Social Interaction Anxiety Scale. MADRS-SR=The Montgomery Åsberg Depression
Rating Scale–Self Report. SD= standard deviation. ES= Eﬀect size. a= post-treatment. b= Follow-up. ri,s = correlation between level and change.
Table 3
Estimated primary and secondary symptom mean values.
SPS SIAS MADRS-SR
Mean (SD) ES Mean (SD) ES Mean (SD) ES
Pre 40.56 (14.73) 45.89 (9.58) 17.63 (7.31)
M 1 – – 17.12 (7.26) 0.07
M 2 40.56 (14.73) 0.00 16.54 (7.25) 0.14
M 3 37.38 (14.31) 0.21 44.73 (9.42) 0.11 15.42 (7.32) 0.29
M 4 34.61 (14.25) 0.39 15.38 (7.32) 0.30
M 5 32.64 (14.39) 0.52 13.75 (7.67) 0.52
M 6 30.52 (14.70) 0.66 39.31 (9.43) 0.63 13.07 (7.89) 0.60
M 7 28.60 (15.11) 0.79 12.96 (7.94) 0.62
M 8 27.31 (15.46) 0.88 12.73 (8.02) 0.65
M 9 25.43 (16.05) 1.00 34.42 (10.48) 1.10 12.58 (8.08) 0.67
Note. N=169. M=module. SPS= Social Phobia Scale. SIAS= Social
Interaction Anxiety Scale. MADRS-SR=The Montgomery Åsberg Depression
Rating Scale–Self Report. SD= Standard deviation. ES= eﬀect size.
Fig. 1. Magnitude of change.
Note. N=169. M=module. SPS= Social Phobia Scale.
SIAS= Social Interaction Anxiety Scale. MADRS-
SR=The Montgomery Åsberg Depression Rating
Scale–Self Report.
Table 4
Clinically reliable changes at post-treatment measured by social phobia scale.
Recovered Improved Unchanged Deteriorated
Completed main parts
(n=96)
45 (46.9%) 28 (29.2%) 13 (13.5%) 10 (10.4%)
Did not complete main
parts (n=49)
4 (8.2%) 19 (38.8%) 12 (24.5%) 14 (28.6%)
Total (N=145) 49 (33.8%) 47 (32.4%) 25 (17.2%) 24 (16.6%)
Note. N=145. Recovered= clinical change and reliable change.
Improved= reliable change. Unchanged=no clinical or reliable change.
Deteriorated= negative reliable change. Completed main parts= completed
ﬁve modules or more. Did not complete main parts= stopped at module four or
before.
T. Nordgreen et al. Internet Interventions 13 (2018) 24–29
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3.8. Treatment credibility
Treatment credibility was rated as moderate to high on all items,
with a mean score of 6.9 (range=1–10, SD=1.73). A total of 107 of
143 (74.8%) patients would recommend the treatment to a friend.
4. Discussion
This study examined the eﬀectiveness of guided ICBT in routine care
in secondary mental health services in Norway. A total of 222 GP-re-
ferred patients were eligible for guided ICBT for SAD, out of which 169
provided informed consent for this study and were included, and 145
patients (85.8%) subsequently started treatment. On average, the
sample had had their complaints for nearly 14 years, and 40% were
married or cohabitating. Moreover, the majority (80%) had received
other mental healthcare services in the last six months, and one of three
participants in the sample was on sick leave, receiving a disability
pension, or unemployed. Comparable eﬀectiveness studies have sam-
ples with considerably higher educational levels (El Alaoui et al., 2015;
Kok et al., 2014) and a lower proportion of participants on sick leave,
receiving a disability pension, or unemployed (El Alaoui et al., 2015).
Positive signiﬁcant changes were reported on primary and sec-
ondary outcome measures. Large treatment eﬀects were reported on the
primary outcome measure—the SPS—at post-treatment and at follow-
up. Moderate and large treatment eﬀects were reported on the sec-
ondary outcome measures—the SIAS and MADRS-SR—at post-treat-
ment and the six-month follow-up. A signiﬁcant improvement was re-
ported by 66.2% of the sample.
The treatment eﬀects of guided ICBT for SAD reported in this study
are comparable to ﬁndings from previous eﬃcacy (Boettcher et al.,
2013) and eﬀectiveness (El Alaoui et al., 2015; Newby et al., 2014)
studies. The improvement rate of ICBT for SAD of 66% in the current
trial is higher compared to improvement rates reported in a recent
Cochrane review (50%; Olthuis et al., 2016).
Patients in the current trial completed a mean of 5.3 out of nine
(59%) modules. This is somewhat lower compared to a mean comple-
tion of 8.2 out of 12 (68%) modules in the El Alaoui trial and higher
compared to the three out of eight (38%) completed exercises in the
Kok et al. (2014) trial. However, it should be noted that Kok et al.'s trial
and the present one are both from secondary mental healthcare settings
where all patients are GP-referred to a general mental health clinic
where ICBT is one of several treatment formats. This is diﬀerent from
the setting of self-referred patients at a specialized ICBT clinic in the El
Alaoui et al. (2015) trial.
A total of 16.6% of the participants in the current trial had a sig-
niﬁcant deterioration after starting treatment. This is higher than the
5.8% reported in a recent individual patient data meta-analysis of de-
terioration of ICBT trials (Rozental et al., 2017). The relatively high
deterioration rate may reﬂect limitations of the platform used (inﬂex-
ibility) or the implementation of ICBT in routine care with GP referrals
only. However, the diﬀerence between the meta-analysis and the cur-
rent trial may also reﬂect variance in patient characteristics on sick
leave/unemployment (6–11% versus 36%), 12+ educational level
(64% versus 29%), cohabitants (66% versus 40%), or psychotropic
medication (32% versus 40%). This interpretation is in line with pre-
vious research showing that having a university degree is associated
with a lower degree of deterioration (Rozental et al., 2017).
The present study has limitations, the main one being the lack of a
control group. However, the eﬃcacy of this treatment has been re-
ported in previous randomized controlled trials, showing that the
treatment, and not time alone, contributes to short-term (Andersson
et al., 2006; Carlbring et al., 2007; Nordgreen et al., 2016; Nordmo
et al., 2015) and long-term eﬀects (Carlbring et al., 2009; Andersson
et al., 2018). Also, in a recent meta-analysis of waitlist control groups in
randomized trials for SAD (Steinert et al., 2017), time alone had a very
limited eﬀect on improvement. Further, when comparing the eﬀects of
active treatment to waitlist control across 30 randomized trials
(N=2460), the within-group eﬀect sizes were large for treatment
(g= 0.86) and small for waitlist (g= 0.13). Ten of the 30 studies were
internet or self-help based. This supports the notion that SAD is often
chronic if not treated, and time alone cannot explain treatment eﬀects
in open trials. Another limitation is the lack of diagnostic interviews
post-treatment by independent assessors. In line with routine care, this
was not implemented in this eﬀectiveness trial. Finally, a low response
rate of 35.9% at the six-month follow-up is a limitation. According to
routine care, we only sent one automatic reminder to the participants at
the six-month follow-up. This makes generalizability to the total sample
diﬃcult.
The main strength of the current study is the documentation of the
eﬀects of guided ICBT for SAD after implementation during routine care
in a relatively large sample. Another strength is the documentation of
the eﬀects of guided ICBT of SAD on a GP-referred sample.
The clinical implication of the current study is that guided ICBT for
SAD is an eﬀective treatment for the majority of participants under-
going routine care. This study shows that this is also true when the
patients have a relatively low educational level and high work absence.
The rate of deterioration in this study underlines the importance of
clinical monitoring and reporting of negative eﬀects in clinical care
services. Future studies need to explore interventions targeting non-
responders and deteriorated patients.
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